China Health (00673) will be suspended from trading starting from July 2nd, awaiting the publication of the 2025 annual performance.
China Health Group (00673) announced that the company's shares will be traded in Hong Kong starting from 9:00 a.m. on July 2, 2025.
China Health (00673) has announced that trading of the company's shares on the Stock Exchange of Hong Kong will be suspended from 9:00 am on July 2, 2025, pending the publication of the company's audited annual performance for the year ended March 31, 2025.
Related Articles
CENTURY GINWA (00162): Ma Wenzhong appointed as Chairman of the Board
CSTONE PHARMA-B(02616) first disclosed two new dual-antibody molecular targets for autoimmune/inflammatory diseases.
China Securities Co., Ltd.: The market in July is expected to trade around the mid-year reports, focusing on overseas computing power chains and other directions.
CENTURY GINWA (00162): Ma Wenzhong appointed as Chairman of the Board
CSTONE PHARMA-B(02616) first disclosed two new dual-antibody molecular targets for autoimmune/inflammatory diseases.
China Securities Co., Ltd.: The market in July is expected to trade around the mid-year reports, focusing on overseas computing power chains and other directions.
RECOMMEND
U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025
Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025
Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025
